Rituximab therapy for refractory systemic-onset juvenile idiopathic arthritis | Annals of the Rheumatic Diseases

Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Archive
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals More

You are viewing from: Department GEZ-LTA Erasmushogeschool

Article Text

Letter

Rituximab therapy for refractory systemic-onset juvenile idiopathic arthritis

https://doi.org/10.1136/ard.2008.092106

Statistics from Altmetric.com

Footnotes

Competing interests: None.
Ethics approval: Ethics approval was obtained.
Patient consent: Obtained.

Read the full text or download the PDF: